CD14 and coronary artery disorder: In the present study, we provide evidence for the first time that in patients with stable CAD and elevated serum levels of the highly proatherogenic Lp(a), monocyte subset distribution exhibits a more proatherogenic pattern evidenced by elevated levels of the proinflammatory subset of IM, defined as CD14++CD16+ cells that has been shown to be predictive for cardiovascular events.19